Stephen Croskrey - Jul 23, 2021 Form 4 Insider Report for Danimer Scientific, Inc. (DNMR)

Role: CEO and Chairman of the Board, Director
Signature: /s/ Stephen E. Croskrey
Stock symbol: DNMR
Transactions as of: Jul 23, 2021
Transactions value $: $0
Form type: 4
Date filed: 7/27/2021, 04:42 PM
Next filing: Sep 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNMR	Performance Stock Award	Award	$0	+95.9K		$0.00	95.9K	Jul 23, 2021	Class A Common Stock ("Common Stock")	95.9K	$0.00	Direct	F1, F2, F3, F4, F5
transaction	DNMR	Stock Option (right to purchase)	Award	$0	+244K		$0.00	244K	Jul 23, 2021	Common Stock	244K	$18.24	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Comprised of a performance stock award (the "PSA") granted under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan") consisting of 95,943 performance shares of the Common Stock (the "Performance Shares").
F2	Under the PSA, the Performance Shares shall be issued only if (A) to the extent necessary, after the approval by the shareholders of the Issuer of an amendment to the Plan to increase the number of shares available under the Plan in an amount sufficient to permit the vesting and issuance of the Performance Shares in accordance with the PSA, and (B) they have vested in accordance with the following vesting criteria: (i) 30% of the Performance Shares (the "ROE Metric Shares") shall be subject to vesting upon achievement of the pre-tax return on equity ("ROE") metric as follows: the threshold for vesting the ROE Metric Shares shall be the Issuer achieving ROE of at least 5%, in which event 50% of the ROE Metric Shares shall vest, and upon the Issuer achieving ROE of 9%, 100% of the ROE Metric Shares shall vest, with pro rata vesting of the ROE Metric Shares for any amount of ROE in between such ranges; (ii) 30% of the Performance Shares (the "EBITDA Metric Shares") shall be subject to vesting upon achievement of the earnings before interest, taxes, depreciation and amortization ("EBITDA") metric as follows:
F3	(continuation of footnote 2) the threshold for vesting the EBITDA Metric Shares shall be the Issuer achieving EBITDA of at least $45 million, in which event 50% of the EBITDA Metric Shares shall vest, and upon the Issuer achieving $65 million of EBITDA, 100% of the EBITDA Metric Shares shall vest, with pro rata vesting of the EBITDA Metric Shares for any amount of EBITDA in between such ranges; and (iii) 40% of the Performance Shares (the "Neat Capacity Metric Shares") shall be subject to vesting upon achievement of the nameplate capacity for neat PHA production ("Neat Capacity") metric as follows: the threshold for vesting the Neat Capacity Metric Shares shall be the Issuer achieving a Neat Capacity of at least 75 million pounds, in which event 50% of the Neat Capacity Metric Shares shall vest, and upon the Issuer achieving 90 million pounds of Neat Capacity, 100% of the Neat Capacity Shares shall vest, with pro rata vesting of the Neat Capacity Metric Shares for any amount of Neat Capacity in between such ranges.
F4	ROE shall mean the pre-tax return on equity equal to earnings before taxes divided by the average shareholders' equity, based on the Issuer's consolidated financial statements for the period in question. The vesting of the ROE Metric Shares shall be measured based on the Issuer's audited consolidated financial statements for the fiscal year ended December 31, 2023. EBITDA shall be determined based on the Issuer's consolidated financial statements for the period in question. The vesting of the EBITDA Metric Shares shall be measured based on the Issuer's audited consolidated financial statements for the fiscal year ended December 31, 2023. Neat Capacity shall be determined based upon a third-party certification of the ability of the Issuer to produce the quantities of neat PHA set forth above based on its facilities, and not necessarily actual production of such quantities. The vesting of the Neat Capacity Metric Shares shall be measured as of December 31, 2023.
F5	The earlier of July 23, 2024 or the Reporting Person's Termination Date (as defined in the Plan).
F6	The option to purchase 244,073 shares of the Issuer's Common Stock (the "Option Shares") was granted under the Plan, which shall only be exercisable if (A) to the extent necessary, after the approval by the shareholders of the Issuer of an amendment to the Plan to increase the number of shares available under the Plan in an amount sufficient to permit the exercise of the Option Shares, and (B) the Option Shares have vested, which vesting shall occur as follows: (i) one-third of the Option Shares shall vest on July 23, 2022; (ii) one-third of the Option Shares shall vest on July 23, 2023; and (iii) one-third of the Option Shares shall vest on July 23, 2024.